PillAlfalfa, Borago Officinalis, Calcarea Carbonica, Ceanothus Americanus, Citricum Acidum, Fucus Vesiculosus, Ginkgo Biloba, Glandula Suprarenalis Suis, Glycyrrhiza Glabra, Hydrocotyle Asiatica, Hypothalamus (Bovine), Kali Phosphoricum, Pancreas Suis, Phytolacca Decandra, Pituitarum Posterium (Bovine), Sarsaparilla (Smilax Regelii), Silicea, Syzygium Jambolanum, Taraxacum Officinale, Thyroidinum (Bovine)
Brands: Endocrinpath · Alfalfa + Borage + Oyster Shell Calcium Carbonate, Crude + Ceanothus Americanus Leaf + Anhydrous Citric Acid + Fucus Vesiculosus + Ginkgo + Sus Scrofa Adrenal Gland + Glycyrrhiza Glabra + Centella Asiatica + Bos Taurus Hypothalamus + Potassium Phosphate, Dibasic + Sus Scrofa Pancreas + Phytolacca Americana Root + Bos Taurus Pituitary Gland + Smilax Ornata Root + Silicon Dioxide + Syzygium Cumini Seed + Taraxacum Officinale + Thyroid, Bovine
1 active makers
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Energetix Corporation | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.